Video

MRD Results and Guiding Treatment Decisions

Kashyap Patel, MD, and Jason Starr, DO, explain the various potential uses for MRD results and how they guide treatment decisions.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
EHA 2025 Congress Recap | Image Credit: Venngage
Related Content
FDA Approved
June 18th 2025

Twice-Yearly Lenacapavir Approval Marks Major Milestone in Prevention of HIV

Julia Bonavitacola
The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year.
managed care cast logo
December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Adalimumab | Image credit: luchschenF - stock.adobe.com
June 16th 2025

Methotrexate Adds No Benefit to Adalimumab in Psoriasis Treatment, Study Suggests

Pearl Steinzor
Target trial emulation study finds no added effectiveness or persistence with combination therapy for plaque psoriasis.
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
Follicular lymphoma | Image: The Follicular Lymphoma Foundation
June 14th 2025

A Look at Those With Durable Responses to Epcoritamab in LBCL

Mary Caffrey
A post-hoc analysis of EPCORE-NHL-1 was presented at ASCO.
DNA in test tube of blood | Image Credit: © Connect world - stock.adobe.com
June 14th 2025

EHA Plenary Abstracts Zoom in From Investigational Drugs to Molecular Signatures

Christina Mattina
Abstracts presented during the plenary session of the 2025 European Hematology Association (EHA) Congress spanned from novel drug regimens for myeloma and lymphoma to investigation of leukemias on the molecular and genetic levels.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo